Correction to: Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants

Author unknown

Open source

DOI
10.1093/infdis/jiag161
Published
2026-03-18
Container
The Journal of Infectious Diseases
Publisher
Oxford University Press (OUP)
Open access
unknown

Credibility signals

uncertain Score 58/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/infdis/jiag161,
  title = {Correction to: Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants},
  year = {2026},
  journal = {The Journal of Infectious Diseases},
  doi = {10.1093/infdis/jiag161},
  url = {https://doi.org/10.1093/infdis/jiag161}
}

RIS

TY  - JOUR
TI  - Correction to: Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants
PY  - 2026
JO  - The Journal of Infectious Diseases
DO  - 10.1093/infdis/jiag161
UR  - https://doi.org/10.1093/infdis/jiag161
ER  - 

APA

Correction to: Hybrid B- and T-Cell Immunity Associates With Protection Against Breakthrough Infection After Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination in Avon Longitudinal Study of Parents and Children (ALSPAC) Participants. (2026). The Journal of Infectious Diseases. https://doi.org/10.1093/infdis/jiag161

Source records